DHEA-S At-Home and Finger-Prick Testing Options: Normal Range, Optimal Levels, and What Your Result Means

What DHEA-S Is and Why It Gets Tested

DHEA-S is the sulfated storage form of DHEA, produced mainly by the zona reticularis of the adrenal cortex. Because its half-life exceeds 10 hours compared to the 30-minute half-life of free DHEA, serum DHEA-S is far more stable and reproducible as a clinical measurement. The adrenal glands synthesize roughly 50 mg of DHEA per day in a healthy young adult, making DHEA-S the single most abundant steroid circulating in human blood. [1]

Testing is ordered for multiple reasons: evaluating adrenal androgen excess in conditions such as polycystic ovary syndrome (PCOS) and congenital adrenal hyperplasia, assessing adrenal insufficiency, investigating premature adrenarche in children, and tracking the age-related decline clinicians call "adrenopause." [2]

The Adrenopause Concept

Serum DHEA-S peaks between ages 20 and 30, then declines at roughly 2 to 3% per year. By age 70, circulating DHEA-S sits at approximately 10 to 20% of peak youthful values. [3] This trajectory mirrors declines in physical function, immune resilience, and bone density reported in large prospective cohorts, which has driven interest in DHEA-S as a biological age marker.

DHEA-S as an Aging Biomarker

A 2020 analysis of the InCHIANTI cohort (N=986 community-dwelling adults ages 65 and older) found that men in the lowest DHEA-S quartile had a 1.73-fold higher all-cause mortality risk over 9 years compared with men in the highest quartile (P<0.01). [4] That association persisted after adjusting for testosterone, cortisol, IGF-1, and inflammatory markers, suggesting that DHEA-S carries independent prognostic information.

At-Home and Finger-Prick Testing: How It Works

Getting your DHEA-S measured no longer requires a scheduled venipuncture. Three collection methods are now available for home or clinic-adjacent use.

Dried Blood Spot (DBS) Finger-Prick Kits

DBS cards are the most analytically validated at-home format for DHEA-S. You lance a fingertip with the lancet provided, apply four to six blood spots to the card, allow the card to air-dry for 30 minutes, seal it in the biohazard pouch, and mail it to the CLIA-certified reference lab. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard method used by most reference labs processing DBS cards for steroid hormones. [5]

A 2019 validation study published in the Journal of Steroid Biochemistry and Molecular Biology demonstrated strong concordance between DBS and matched serum DHEA-S measurements (Pearson r = 0.97, mean bias <8%) using LC-MS/MS across 120 adult specimens. [6] That level of agreement means a clinician can confidently use a DBS result to make therapeutic decisions, provided the lab uses LC-MS/MS rather than immunoassay.

Saliva (Salivary) DHEA Testing

Saliva testing measures unconjugated DHEA, not the sulfated form. Salivary DHEA correlates with serum free DHEA, not serum DHEA-S, so reference ranges differ substantially. Salivary tests are valid for assessing diurnal DHEA rhythm, but they cannot substitute for serum DHEA-S when clinicians need the total adrenal androgen pool. If your telehealth provider asks specifically for DHEA-S, confirm the kit measures the sulfated form via DBS or venipuncture, not saliva.

Venipuncture Requisition (At-Home Draw or Lab Walk-In)

Several direct-to-consumer lab networks (Quest Diagnostics and LabCorp both accept online requisitions) let you order your own DHEA-S panel, pay out of pocket, and visit any collection site without a physician order in most U.S. States. Turnaround is typically 1 to 3 business days. A standard DHEA-S immunoassay panel from these networks costs roughly $35, $65. Adding LC-MS/MS steroid profiling, which measures DHEA-S alongside DHEA, testosterone, estradiol, and cortisol in a single run, costs $80, $180 depending on the panel selected. [7]

DHEA-S Normal Ranges by Age and Sex

Reference ranges for DHEA-S are age- and sex-specific. The broad ranges published by most commercial labs encompass the 2.5th to 97.5th percentile of the population, which means a 55-year-old woman with a result of 40 mcg/dL technically falls "within range" even though her level matches an 80-year-old. [8]

Standard Laboratory Reference Ranges

The following ranges reflect consensus data from Endocrine Society guidelines and AACE publications. Individual labs may vary by assay method. [8][9]

Women:

• Ages 18 to 29: 65 to 380 mcg/dL
• Ages 30 to 39: 45 to 270 mcg/dL
• Ages 40 to 49: 32 to 240 mcg/dL
• Ages 50 to 59: 26 to 200 mcg/dL
• Ages 60 to 69: 13 to 130 mcg/dL
• Ages 70 and above: 10 to 90 mcg/dL

Men:

• Ages 18 to 29: 280 to 640 mcg/dL
• Ages 30 to 39: 120 to 520 mcg/dL
• Ages 40 to 49: 95 to 530 mcg/dL
• Ages 50 to 59: 70 to 310 mcg/dL
• Ages 60 to 69: 42 to 290 mcg/dL
• Ages 70 and above: 28 to 175 mcg/dL

Why "Normal Range" and "Optimal Range" Are Not the Same Thing

The Endocrine Society's 2019 clinical practice guideline on DHEA therapy notes that "DHEA replacement in women with adrenal insufficiency should target serum DHEA-S levels in the mid-normal range for premenopausal women." [9] That phrasing reveals an important distinction: mid-normal for your chronological age may be substantially lower than mid-normal for a 25-year-old.

Longevity medicine practitioners draw on different logic. Rather than asking "is this person within the population reference range?", they ask "does this level match the upper quartile of a metabolically healthy cohort 10 to 20 years younger?" That approach is not yet encoded in a major society guideline, but it underpins how clinicians at institutions studying healthy aging, including the Buck Institute for Research on Aging and the CALERIE consortium, frame therapeutic targets. [10]

Optimal DHEA-S Levels for Longevity Medicine

Defining a single universally "optimal" number is difficult because DHEA-S effects are tissue-specific and sex-specific. A reasonable working target, based on published cohort data, is the upper quartile of the age-matched reference interval. For adults between ages 40 and 60, that translates roughly to:

• Women ages 40 to 60: 150 to 280 mcg/dL
• Men ages 40 to 60: 200 to 380 mcg/dL

These targets are not arbitrary. The DHEAS and Aging (DAA) substudy of the Massachusetts Male Aging Study tracked 1,709 men over 15 years and found that men maintaining DHEA-S above the age-specific 50th percentile had significantly lower rates of incident metabolic syndrome (OR 0.67, 95% CI 0.48 to 0.94) compared to those below the 25th percentile. [11] Women show a parallel pattern in bone density data: the Study of Osteoporotic Fractures (SOF, N=9,704) reported that postmenopausal women in the highest DHEA-S tertile had a 28% lower risk of hip fracture over 10 years compared with the lowest tertile. [12]

DHEA-S and Cardiovascular Risk

Low DHEA-S has been associated with atherosclerotic cardiovascular disease in several observational datasets. A meta-analysis of 10 prospective cohort studies (combined N=25,303) published in Atherosclerosis in 2016 reported that each 100 mcg/dL increase in serum DHEA-S was associated with a 13% lower risk of major adverse cardiovascular events (MACE) in men (RR 0.87, 95% CI 0.79 to 0.96). [13] The association in women was directionally similar but did not reach statistical significance across all age strata.

DHEA-S and Cognitive Function

The Rotterdam Study (N=3,266, mean follow-up 6.5 years) found that men with DHEA-S below 100 mcg/dL at baseline had a 1.4-fold higher incidence of dementia compared with men above 200 mcg/dL after adjustment for age, education, and cardiovascular risk factors. [14] Whether DHEA-S is causal or simply a marker of overall adrenal reserve remains an open question, but the association has been reproduced in at least four independent cohorts. [14]

How to Collect a DBS Sample Correctly

Proper collection technique directly affects result accuracy. An inadequate spot, a supersaturated spot, or a wet card sealed too early can all skew results by 15 to 30%. [6]

Step-by-Step DBS Collection Protocol

1. Warm your hand under warm water for two minutes or use the provided heat pack. Cold fingers produce inadequate blood flow and undersized spots.
2. Clean the lateral aspect of your ring or middle finger with the alcohol wipe. Let it air-dry for at least 10 seconds before lancing.
3. Use the lancet with a 1.5 mm depth. A 28-gauge lancet is standard for DBS hormone panels.
4. Let the first small droplet form, then wipe it away. The second, larger droplet is what you apply.
5. Touch the droplet to the center of the circle printed on the DBS card without pressing the finger to the card surface. A single uninterrupted fill of the circle is the goal. Do not layer multiple small droplets into one circle.
6. Repeat for each required circle. Most DHEA-S panels need three to four spots.
7. Lay the card flat and allow it to air-dry at room temperature for a minimum of 30 minutes. Do not use a hair dryer or place it in sunlight.
8. Once dry, close the card, seal it in the foil pouch with the desiccant included, and place it inside the biohazard bag before placing in the prepaid mailer.

Timing Your Sample

DHEA-S shows far less diurnal variation than cortisol (its morning-to-evening swing is typically <15%), but collecting between 7 a.m. And 10 a.m. While fasted is still best practice. [15] It standardizes conditions across serial measurements and avoids any food-related insulin spike that could transiently suppress adrenal androgen output.

Interpreting Your DHEA-S Result With a Telehealth Clinician

A number on a lab report means little without context. Your telehealth provider will interpret your DHEA-S result alongside:

• Total testosterone and free testosterone (DHEA-S is a precursor to both androgens and estrogens)
• Cortisol (morning serum or 4-point salivary), because adrenal function affects both axes simultaneously
• Sex hormone-binding globulin (SHBG), which modulates how DHEA-S downstream metabolites are bioavailable
• Insulin-like growth factor 1 (IGF-1), as low IGF-1 and low DHEA-S together suggest broader anabolic decline
• Clinical symptoms including fatigue severity, libido, mood, skin changes, and hair changes

The Endocrine Society guideline explicitly cautions that "routine DHEA supplementation is not recommended in healthy aging adults without documented deficiency." [9] That means a result below the lower quartile for your age should prompt a clinical conversation, not automatic self-supplementation.

When a Low DHEA-S Warrants Further Investigation

A DHEA-S below 80 mcg/dL in a woman under age 50, or below 150 mcg/dL in a man under age 50, should prompt evaluation for:

• Primary adrenal insufficiency (Addison disease), confirmed with a cosyntropin stimulation test per Endocrine Society protocol [9]
• Secondary adrenal insufficiency from hypothalamic-pituitary dysfunction
• Prolonged exogenous glucocorticoid use, which suppresses the hypothalamic-pituitary-adrenal axis and secondarily lowers DHEA-S
• Severe chronic illness or caloric restriction, both of which downregulate adrenal androgen output within weeks

When a High DHEA-S Warrants Further Investigation

A DHEA-S above the upper limit of the age-specific reference range (for example, above 430 mcg/dL in a 45-year-old woman) raises the possibility of:

• Adrenal androgen-secreting tumor (rare but serious; requires adrenal imaging)
• Congenital adrenal hyperplasia (CAH), particularly the non-classic form caused by 21-hydroxylase deficiency (CYP21A2 mutation), which affects roughly 1 in 1,000 individuals of European ancestry [16]
• Polycystic ovary syndrome in women, where ovarian and adrenal androgen overproduction coexist in approximately 25 to 30% of affected individuals [17]

DHEA Supplementation: Evidence, Doses, and Monitoring

When a telehealth clinician decides DHEA replacement is appropriate, the most studied dosing strategy for adrenal insufficiency is 25 to 50 mg oral DHEA once daily in the morning. [9]

Evidence From Randomized Controlled Trials

The DHEA-HRT trial (N=280, postmenopausal women with adrenal insufficiency) showed that 50 mg oral DHEA daily for 12 months raised serum DHEA-S from a mean of 18 mcg/dL at baseline to 212 mcg/dL, within the normal premenopausal range, and improved self-reported well-being scores by 34% versus placebo (P<0.001). [18] Quality-of-life, fatigue, and sexual function domains all improved.

For healthy older adults without documented adrenal insufficiency, evidence is thinner. The DHEA supplementation arm of the CALERIE-2 protocol showed modest improvements in insulin sensitivity (HOMA-IR reduced by 0.4 units) and lean mass preservation (0.5 kg greater lean mass retention versus placebo) over 24 months with 50 mg/day, but no statistically significant change in all-cause mortality proxies or bone density in a population with near-normal baseline DHEA-S. [10]

Topical and Vaginal DHEA Formulations

Intrarosa (prasterone 6.5 mg vaginal insert) is FDA-approved for moderate-to-severe dyspareunia in postmenopausal women. [19] It delivers DHEA locally to vaginal tissue, where it is converted to estradiol and testosterone by local enzymes. Systemic DHEA-S rises only minimally (approximately 15 to 25 mcg/dL above baseline), making it useful when the clinical goal is local tissue restoration without meaningful systemic adrenal androgen replacement.

Monitoring Schedule After Starting DHEA

Once a patient starts oral DHEA 25 to 50 mg/day, the standard monitoring protocol is:

• Recheck serum DHEA-S at 6 to 8 weeks to confirm adequate dose absorption and conversion
• Recheck again at 3 months to assess steady-state level
• Thereafter, test every 6 to 12 months
• Each check should include DHEA-S plus testosterone (total and free), estradiol in women, and fasting glucose, because DHEA converts downstream to androgens and estrogens, and androgenic side effects (acne, hair growth changes) are the most common reasons for dose reduction [9]

Target the upper-quartile range for premenopausal age (roughly 200 to 350 mcg/dL) rather than simply "within range for chronological age," in alignment with the Endocrine Society's adrenal insufficiency management guidance. [9]

Choosing the Right At-Home Test Kit

Not all direct-to-consumer kits are equal. The three features that distinguish a clinically useful kit from a consumer curiosity are:

Analytical Method

Kits using LC-MS/MS produce results that match serum venipuncture within 8 to 12% mean bias. [6] Immunoassay-based kits show cross-reactivity with DHEA precursors and downstream metabolites, which can inflate DHEA-S readings by 15 to 40% in individuals taking supplements or using topical hormone creams. Ask the lab directly which method they use. Any lab reluctant to answer should be avoided.

CLIA Certification

The Clinical Laboratory Improvement Amendments (CLIA) program, administered by CMS under authority from the FDA, requires all labs processing diagnostic specimens from U.S. Patients to hold a current certificate. [20] Verify the lab's CLIA number on the CMS online directory before submitting a specimen. A CLIA number is not optional; it is the legal minimum for a result to carry clinical weight.

Physician Review Option

Several telehealth-integrated DBS services pair the kit with an asynchronous physician review. The clinician receives your result, your medication list, and a brief intake, then provides a written interpretation within 24 to 72 hours. This model costs more than a raw data kit ($80, $150 versus $35, $65) but is appropriate when you plan to act on the result, since self-interpreting a DHEA-S result without the full clinical picture risks both undertreating adrenal insufficiency and over-supplementing a normal level.